Your browser doesn't support javascript.
loading
Gliclazide in Binary and Ternary Systems Improves Physicochemical Properties, Bioactivity, and Antioxidant Activity.
Ibrahim, Muhammad; Munir, Shehla; Ahmed, Sarfraz; Chughtai, Adeel Hussain; Ahmad, Waqas; Khan, Jallat; Murtey, Mogana Das; Ijaz, Hira; Ojha, Suvash Chandra.
Afiliação
  • Ibrahim M; Department of Biochemistry, Bahauddin Zakariya University, Multan 60800, Pakistan.
  • Munir S; Department of Biochemistry, Bahauddin Zakariya University, Multan 60800, Pakistan.
  • Ahmed S; Department of Basic Sciences, University of Veterinary and Animal Sciences Lahore, Narowal Campus, Narowal 51600, Pakistan.
  • Chughtai AH; Institute of Chemical Sciences, Bahauddin Zakariya University, Multan 60800, Pakistan.
  • Ahmad W; Department of Clinical Sciences, University of Veterinary and Animal Sciences Lahore, Narowal Campus, Narowal 51600, Pakistan.
  • Khan J; Department of Chemistry, Khwaja Fareed University of Engineering & Information Technology, Rahim Yar Khan 64200, Pakistan.
  • Murtey MD; Basic Sciences and Oral Biology Unit, School of Dental Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia.
  • Ijaz H; Department of Pharmacy, Pak-Austria Fachhochschule Institute of Applied Sciences and Technology, Mang, Haripur 22620, Khyber Pakhtunkhwa, Pakistan.
  • Ojha SC; Department of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Oxid Med Cell Longev ; 2022: 2100092, 2022.
Article em En | MEDLINE | ID: mdl-36466089
ABSTRACT
The poor solubility of the antidiabetic drug gliclazide (Glc) is due to its hydrophobic nature. This research is aimed at improving Glc's solubility and drug release profile, as well as at investigating additional benefits such as bioactivity and antioxidant activity, by forming binary complexes with HPßCD at different w/w ratios (1 1, 1 2.5, 1 4, and 1 9) and ternary complexes with HPßCD and Tryp at 1 1 1, 1 1 0.27, 1 2.5 0.27, 1 3.6 3.6, 1 4 1, and 1 9 1, respectively. Complexes were prepared by the physical mixing (PM) and solvent evaporation (SE) methods. The prepared inclusion complexes were meticulously characterized by X-ray diffractometry (XRD), scanning electron microscopy (SEM), and attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectra. To verify our findings, the inclusion complexes were evaluated by equilibrium solubility, in vitro drug release profile, kinetic models, and antidiabetic and antioxidant activities in animal models. Our results demonstrated that the solubility and drug release profile were found to be enhanced through binary as well as ternary complexes. Notably, ternary complexes with a ratio of 1 9 1 showed the highest solubility and drug release profile compared to all other preparations. Data on antioxidant activity indicated that the ternary complex had the higher total antioxidant status (TAS), superoxide dismutase (SOD), and catalase (CAT) activity than the binary complex and Glc alone, in contrast to the diabetic group. In vivo antidiabetic activity data revealed a high percentage reduction in the blood glucose level by ternary complexes (49-52%) compared to the binary complexes (45-46%; p ≤ 0.05). HPßCD and Tryp provide a new platform for overcoming the challenges associated with poorly soluble Glc by providing greater complexing and solubilizing capabilities and imparting ancillary benefits to improve the drug's antidiabetic and antioxidant activities.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gliclazida Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Oxid Med Cell Longev Assunto da revista: METABOLISMO Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Paquistão País de publicação: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gliclazida Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Oxid Med Cell Longev Assunto da revista: METABOLISMO Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Paquistão País de publicação: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA